Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS.

Neurology·2009
Same author

Gout in the transplant patient.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

And then there were two: the cyclooxygenase story can the expectations be fulfilled?

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Systemic vasculitis and polyarthritis as the presenting feature of renal cell carcinoma.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Systemic lupus erythematosus-associated alveolar hemorrhage: presentation, treatment, and outcome.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data.

Multiple sclerosis (Houndmills, Basingstoke, England)·2008
Same journal

Risk of Femoral Head Osteonecrosis Following Hip Trauma in Adults With Systemic Lupus Erythematosus.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2026
Same journal

Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE Study: Erratum.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2026
Same journal

Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early and Late Disease Through One Year of the GO-ALIVE Study: Erratum.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2026
Same journal

Microbiome Dysbiosis as a Potential Driver of Inflammatory Mimicry in Pachydermoperiostosis-associated Hypertrophic Osteoarthropathy.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2026
Same journal

Understanding Gaps in Methotrexate Education in the Adolescent and Young Adult Population.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2026
Same journal

Prevalence of Attention Deficit Hyperactivity Disorder in Adult Patients With Fibromyalgia.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2026

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

Intravenous gamma-globulin therapy.

B F Mandell

    Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
    |December 17, 2008
    PubMed
    Summary
    This summary is machine-generated.

    Intravenous gamma-globulin (IVIg) is now a key treatment for autoimmune disorders beyond its initial use for hypogammaglobulinemia. Its effectiveness is recognized across diverse conditions, making it a valuable therapeutic option.

    More Related Videos

    Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
    13:08

    Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

    Published on: September 9, 2011

    Intravitreal Injections in the Ovine Eye
    03:37

    Intravitreal Injections in the Ovine Eye

    Published on: July 5, 2022

    Related Experiment Videos

    Last Updated: Jun 27, 2026

    Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
    07:57

    Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

    Published on: August 25, 2022

    Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
    13:08

    Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

    Published on: September 9, 2011

    Intravitreal Injections in the Ovine Eye
    03:37

    Intravitreal Injections in the Ovine Eye

    Published on: July 5, 2022

    Area of Science:

    • Immunology
    • Therapeutics
    • Autoimmune Diseases

    Background:

    • Intravenous gamma-globulin (IVIg) was initially developed for hypogammaglobulinemia.
    • IVIg is now widely adopted for treating various autoimmune conditions.
    • Despite its cost, IVIg is a crucial therapeutic agent.

    Purpose of the Study:

    • To review the expanding applications of IVIg in autoimmune disorders.
    • To highlight the established and potential uses of IVIg therapy.

    Main Methods:

    • Review of clinical studies and FDA-approved indications for IVIg.
    • Analysis of IVIg's role in diverse autoimmune and immunodeficiency syndromes.

    Main Results:

    • IVIg is first-line or adjunctive therapy for thrombocytopenia, hemolytic anemia, Kawasaki's disease, myositis, myasthenia gravis, and demyelinating polyneuropathy.
    • IVIg is the primary treatment for humoral immunodeficiency syndromes.
    • IVIg has FDA approval for primary humoral immunodeficiencies and autoimmune thrombocytopenic purpura.

    Conclusions:

    • IVIg is a versatile treatment for numerous autoimmune and immunodeficiency disorders.
    • Clinical evidence supports the use of IVIg in specific patient populations.
    • Further research may explore IVIg's efficacy in other diseases.